Skip to main content

Table 4 Results of BDCAF in the studied BD patients

From: Expression of miR-146a and miR-155 in Egyptian patients with Behçet’s disease: clinical significance and relationship with disease activity

  No. of pt. (total no. = 60) %
Headache 18 30
Mouth ulceration 18 30
Genital ulceration 8 13.3
Erythema 6 10
Skin pustules 15 25
Joint arthalgia 20 33.3
Joint arthritis 19 31.6
Nausea/vomiting/abdominal pain 9 15
Diarrhea & bleeding per rectum 6 10
Eye involvement 39 65
Nervous system involvement 27 45
Major vessel involvement 17 28.3
  Mean ± standard deviation Range
Total current activity from 2006 2.35 ± 2.25 0–9